Sort
51,593 grants matching “hepatitis”
Molecular Approaches To Vaccine Development For Hepatitis C
$506,679T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Molecular signatures for liver cancer diagnosis and treatment stratification
$506,599Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$506,599Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Increasing Hep B screening among Korean church attendees
$506,597Roshan Bastani · University Of California At Davis · P01 · FY2007 · CA
Genetic Viral and Host Adaptations to Breach Species Barriers of HCV
$506,524Alexander Ploss · Princeton University · R01 · FY2018 · AI
Studies on RNAi Based Delivery in Vivo
$506,503Mark A Kay · Stanford University · R01 · FY2013 · DK
Copper Homeostasis and Liver Function
$506,500Svetlana Lutsenko · Johns Hopkins University · R01 · FY2021 · DK
Copper Homeostasis and Liver Function
$506,500Svetlana Lutsenko · Johns Hopkins University · R01 · FY2020 · DK
Copper Homeostasis and Liver Function
$506,500Svetlana Lutsenko · Johns Hopkins University · R01 · FY2019 · DK
Liver Tissue and Cell Distribution System
$506,483Glenn Gourley · University Of Minnesota · N01 · FY2014 · LM
Glycosylation Mutants of Mice and Animal Cells
$506,443Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2007 · CA
Trans Spinal Delivery of Targeted Exosomal Formulation of Curcuminoids to Treat AD
$506,434Ramesh C Gupta · 3p Biotechnologies, Inc. · R41 · FY2025 · AG
New Targets of Thyroid Hormone Action
$506,380Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2015 · DK
New Targets of Thyroid Hormone Action
$506,380Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2016 · DK
New Targets of Thyroid Hormone Action
$506,380Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2014 · DK
Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation
$506,377Peter Philip Reese · University Of Pennsylvania · R01 · FY2023 · DK
Metabolic impact of fructose restriction in obese children
$506,343Jean-Marc Schwarz · Touro University Of California · R01 · FY2014 · DK
Role of the Cell Adhesome in Obesity-related Liver Diseases
$506,338David H Wasserman · Vanderbilt University · R01 · FY2022 · DK
Role of the Cell Adhesome in Obesity-related Liver Diseases
$506,338David H Wasserman · Vanderbilt University · R01 · FY2021 · DK
Role of the Cell Adhesome in Obesity-related Liver Diseases
$506,338Owen P McGuinness · Vanderbilt University · R01 · FY2023 · DK
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
$506,326David E Cohen · Brigham And Women'S Hospital · R01 · FY2022 · DK
The Function of Mammalian LPGAT1
$506,256Michael Schlame · New York University School Of Medicine · R01 · FY2024 · HL
Active, Enhanced Surveillance for Viral Hepatitis in San Francisco, California
$506,246Melissa Sanchez · San Francisco Department Of Public Health · U51 · FY2013 · PS
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy
$506,236Alejandro Soto-Gutierrez · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
$506,214Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2016 · CA